These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9617321)

  • 41. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen.
    Seeger H; Huober J; Wallwiener D; Mueck AO
    Horm Metab Res; 2004 May; 36(5):277-80. PubMed ID: 15156405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice.
    Schafer JM; Lee ES; O'Regan RM; Yao K; Jordan VC
    Clin Cancer Res; 2000 Nov; 6(11):4373-80. PubMed ID: 11106256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.
    Newby JC; Johnston SR; Smith IE; Dowsett M
    Clin Cancer Res; 1997 Sep; 3(9):1643-51. PubMed ID: 9815855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A possible regulatory role of 17beta-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells.
    Rulli A; Antognelli C; Prezzi E; Baldracchini F; Piva F; Giovannini E; Talesa V
    Breast Cancer Res Treat; 2006 Mar; 96(2):187-96. PubMed ID: 16319983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells.
    Larsen SS; Heiberg I; Lykkesfeldt AE
    Br J Cancer; 2001 Mar; 84(5):686-90. PubMed ID: 11237391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
    Gao HD; Sun JZ; Bi DS; Ma R
    Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
    Qu Q; Zheng H; Dahllund J; Laine A; Cockcroft N; Peng Z; Koskinen M; Hemminki K; Kangas L; Väänänen K; Härkönen P
    Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Droloxifene--a novel antiestrogen in endocrine dependent human tumors xenotransplanted into nude mice.
    Stelzer P; Staab HJ; Kömpf J
    Strahlenther Onkol; 1989 Jul; 165(7):559-60. PubMed ID: 2749496
    [No Abstract]   [Full Text] [Related]  

  • 49. [Experimental combined chemo- and endocrine therapy with UFT and tamoxifen in human breast carcinoma xenografts serially transplanted into nude mice].
    Kubota T; Josui K; Ishibiki K; Abe O; Yamada Y; Asanuma F; Kawamura E; Koh J; Shiina E
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2767-73. PubMed ID: 2074386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A permanently charged tamoxifen derivative displays anticancer activity and improved tissue selectivity in rodents.
    Biegon A; Brewster M; Degani H; Pop E; Somjen D; Kaye AM
    Cancer Res; 1996 Oct; 56(19):4328-31. PubMed ID: 8813117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liposomal 4-hydroxy-tamoxifen: effect on cellular uptake and resulting cytotoxicity in drug resistant breast cancer cells in vitro.
    Zeisig R; Teppke AD; Behrens D; Fichtner I
    Breast Cancer Res Treat; 2004 Oct; 87(3):245-54. PubMed ID: 15528967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Preclinical screening of chemotherapeutic and endocrine agents using human tumor xenografts--nude mouse system].
    Kubota T; Ishibiki K; Abe O
    Gan To Kagaku Ryoho; 1991 Jul; 18(9):1439-47. PubMed ID: 1854214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in immunoreactivity of estrogen receptor (ER) in tamoxifen-sensitive and -resistant breast carcinomas: preclinical and first clinical investigations.
    Naundorf H; Jost-Reuhl B; Becker M; Reuhl T; Neumann C; Fichtner I
    Breast Cancer Res Treat; 2000 Mar; 60(1):81-92. PubMed ID: 10845812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experimental chemo- and chemoendocrine therapy of human breast carcinomas serially transplanted into nude mice].
    Koh J
    Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):91-102. PubMed ID: 3129645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of tamoxifen on estrogen-stimulated growth of MCF-7 tumors in athymic mice: preliminary report].
    Iino Y; Izuo M; Jordan VC
    Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):1050. PubMed ID: 2233661
    [No Abstract]   [Full Text] [Related]  

  • 56. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Katsuki Y; Shibutani Y; Aoki D; Nozawa S
    Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice.
    Leung CK; Shiu RP
    Cancer Res; 1981 Feb; 41(2):546-51. PubMed ID: 7448802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
    Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
    Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potentiation of antitumor activity of mitomycin C by estradiol: studies of human breast carcinoma xenografts serially transplanted into nude mice.
    Oka S; Kubota T; Takeuchi T; Kitajima M
    J Surg Oncol; 1996 Apr; 61(4):256-61. PubMed ID: 8627994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
    Arteaga CL; Koli KM; Dugger TC; Clarke R
    J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.